NURS FPX 4000 Assessment 5 Analyzing a Current Healthcare Problem
NURS FPX 4000 Assessment 5 Analyzing a Current Healthcare Problem
- Student name
- Capella University
- NURS FPX 4000 Assessment 5
- Professor’s Name
- Submission Date
Analyzing a Current Healthcare Problem
The opioid crisis remains a persistent problem in the U.S. healthcare system, resulting in mass destruction by causing overdose and chronic health complications, as well as social disruption. Although opioid use disorder (OUD) can be treated, a number of its victims encounter significant obstacles to care (Dowell, 2024). The given assessment is aimed at analyzing the opioid epidemic from the perspective of structured problem-solving to inform better care and policy choices.
Explaining the Healthcare Problem
The number of individuals who undergo OUD and receive the necessary medications (methadone, buprenorphine, or naltrexone) per year is very low (Dowell, 2024). In 2022, merely 25.1 percent of adults in the US who required treatment of OUD were provided with medications of OUD (MOUD), including buprenorphine or methadone, although they were proven to be highly effective in the reduction of overdoses and mortality (Dowell, 2024).
Analyzing Issue Significance Thoroughly
The opioid epidemic has not left any healthcare environment alone, with the emergency department, inpatient unit to manage the withdrawal, community clinics to provide follow-up treatment, and association and visit with the home-recovering to provide care. NURS FPX 4000 Assessment 5 Nurses process pain evaluation, provide harm-reduction counseling, teach individuals, and provide support in the usage of medications, and this crisis is very relevant to the everyday practice (Dydyk et al., 2025).
Evaluating Solution Success Factors
They comprise the expansion of MAT in primary care and specialty clinics. They also encompass the expansion of the harm-reduction services, including the take-home naloxone distribution and syringe-exchange programs, and supervised injection sites (Bremer et al., 2023; Lin, 2022).
Applying Ethical Care Principles
The introduction of large-scale MAT access would presuppose the change of policies to permit the administration of buprenorphine and methadone in primary care, extensive training of nurses and physicians in the field of addiction treatment, and stable reimbursement patterns of MAT services (Madras et al., 2020).
Improving Care Across Spheres
The increase in access to MAT directly helps the wellness and disease-prevention sphere to decrease the risk of fatal overdose and avoid the transition to illicit substances in case of prescription opioid use. Primary care provision of buprenorphine or methadone allows patients to get involved in the recovery process sooner and educates them on safer substance use and overdose prevention (Jalali et al., 2020).
References
Bremer, W., Plaisance, K., Walker, D., Bonn, M., Love, J. S., Phttps://doi.org/10.3389/fpubh.2023.1141093
Dowell, D. (2024). https://doi.org/10.15585/mmwr.mm7325a1
Dydyk, A. M., Jain, N. K., & Gupta, M. (2025). Opioid Use Disorder. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK553166/
Fenske, J. N., Berland, D. W., Chandran, S., http://www.ncbi.nlm.nih.gov/books/NBK572296/
Florence, C., Luo, F., & Rice, K. (2021). https://doi.org/10.1016/j.drugalcdep.2020.108350
Horn, D. B., Vu, L., Porter, B. R., & Afzal, M. (2025). http://www.ncbi.nlm.nih.gov/books/NBK572085/
Humphreys, K., Shover, C. L., Andrews, C. M., Bohnert, A. S. https://doi.org/10.1016/S0140-6736(21)02252-2
Jalali, M. S., Botticelli, M., Hwang, R. C., Koh, H. K., & McHugh, R. K. (2020). https://doi.org/10.1186/s12961-020-00596-8
Lin, K. (2022). https://www.aafp.org/pubs/afp/afp-community-blog/entry/supervised-injection-sites-prevent-opioid-overdose-deaths-improve-public-safety.html
Madras, B. K., Ahmad, N. J., Wen, J., & Sharfstein, J. (2020). https://nam.edu/perspectives/improving-access-to-evidence-based-medical-treatment-for-opioid-use-disorder-strategies-to-address-key-barriers-within-the-treatment-system/